pharma · Idiopathic Hypersomnia · Prader-Willi Syndrome · HRMY
Harmony Biosciences Holdings
Harmony Biosciences Holdings trial registry — 21 ClinicalTrials.gov studies with program phase, status, and indication context.
630 W. Germantown Pike, Suite 220, Plymouth Meeting, PA 19462, US HQ
2017 Founded
332 Employees
Public company Type
HRMY · NYSE Ticker
Company details
- Status
- Public
- HQ
- 630 W. Germantown Pike, Suite 220, Plymouth Meeting, PA 19462, US
- Founded
- 2017
- Employees
- 332
- Programs
- 21
- Drugs
- 14
- Patents
- 6
Harmony Biosciences Holdings clinical trials
Registry index of 21 ClinicalTrials.gov studies linked to Harmony Biosciences Holdings programs — each row shows trial ID, program name, phase, status, and indication.
Harmony Biosciences Holdings trial registry — 21 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Harmony Biosciences Holdings.
-
ZYN2-CL-033 — Phase 3
Clinical update -
HBS-101-CL-312 — Phase 3
Clinical update -
Nutra 1-0602 — Unknown
Clinical update -
Nutra 2-1216 — Unknown
Clinical update -
Pitolisant tablet — Phase 3
Clinical update -
Pitolisant oral tablets — Phase 2
Clinical update -
Pitolisant Oral Tablet — Phase 2
Clinical update -
OVX836 480µg — Phase 2
Clinical update